Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease.

Gender-affirming care Inflammatory bowel disease Sexual and gender minorities Sexual health Sexually transmitted infections

Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
24 Jan 2024
Historique:
received: 16 10 2023
accepted: 14 12 2023
medline: 25 1 2024
pubmed: 25 1 2024
entrez: 24 1 2024
Statut: aheadofprint

Résumé

In recent years, legislation targeting the sexual and gender minority (SGM) community has been passed at an increasingly alarming rate, affecting access to safe and effective gender-affirming care and forcing many SGM patients, including those with inflammatory bowel disease (IBD), to withhold their identities and health concerns. Additionally, SGM patients with IBD may have unique health considerations that have not yet been well-studied OBJECTIVE: This article aims to explore the intersection of IBD and sexual health in patients who identify as SGM and to identify limitations for gastroenterologists in caring for SGM patients. The article also aims to provide suggestions for improvement in SGM-competent care within gastroenterology METHODS: A thorough literature review was conducted regarding sexual health and the SGM community with IBD. This included a review of surgical considerations in SGM patients, sexually transmitted infections (STIs) and prevention, and sexual dysfunction RESULTS: Overall, little is known about the impact of IBD on patients who identify as sexual and gender minorities. Surgery, medications, and STIs continue to be a concern in the SGM community with IBD and these areas represent opportunities to improve SGM-competent IBD care. Additionally, implementation of an SGM-focused curriculum is urgently needed in medical education to improve provider knowledge and care for this unique group of patients CONCLUSIONS: Patients with IBD who identify as SGM experience challenges that are not well described in prior literature. More research is needed and is actively being pursued to guide provider awareness and improve sexual health for this patient population.

Sections du résumé

BACKGROUND BACKGROUND
In recent years, legislation targeting the sexual and gender minority (SGM) community has been passed at an increasingly alarming rate, affecting access to safe and effective gender-affirming care and forcing many SGM patients, including those with inflammatory bowel disease (IBD), to withhold their identities and health concerns. Additionally, SGM patients with IBD may have unique health considerations that have not yet been well-studied OBJECTIVE: This article aims to explore the intersection of IBD and sexual health in patients who identify as SGM and to identify limitations for gastroenterologists in caring for SGM patients. The article also aims to provide suggestions for improvement in SGM-competent care within gastroenterology METHODS: A thorough literature review was conducted regarding sexual health and the SGM community with IBD. This included a review of surgical considerations in SGM patients, sexually transmitted infections (STIs) and prevention, and sexual dysfunction RESULTS: Overall, little is known about the impact of IBD on patients who identify as sexual and gender minorities. Surgery, medications, and STIs continue to be a concern in the SGM community with IBD and these areas represent opportunities to improve SGM-competent IBD care. Additionally, implementation of an SGM-focused curriculum is urgently needed in medical education to improve provider knowledge and care for this unique group of patients CONCLUSIONS: Patients with IBD who identify as SGM experience challenges that are not well described in prior literature. More research is needed and is actively being pursued to guide provider awareness and improve sexual health for this patient population.

Identifiants

pubmed: 38267727
doi: 10.1007/s10620-023-08253-0
pii: 10.1007/s10620-023-08253-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Perez de Arce E, Quera R, Ribeiro Barros J, Yukie Sassaki L. Sexual Dysfunction in Inflammatory Bowel Disease: What the Specialist Should Know and Ask. Int J Gen Med. 2021;14:2003–2015. https://doi.org/10.2147/IJGM.S308214 .
doi: 10.2147/IJGM.S308214 pubmed: 34079340 pmcid: 8163621
Zhao S, Wang J, Liu Y et al. Inflammatory Bowel Diseases Were Associated with Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis. Inflamm Bowel Dis. 2019;25:699–707. https://doi.org/10.1093/ibd/izy345 .
doi: 10.1093/ibd/izy345 pubmed: 30476074
Shmidt E, Suárez-Fariñas M, Mallette M et al. A Longitudinal Study of Sexual Function in Women with Newly Diagnosed Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019;25:1262–1270. https://doi.org/10.1093/ibd/izy397 .
doi: 10.1093/ibd/izy397 pubmed: 30726913
Domislovic V, Brinar M, Cukovic-Cavka S, Turk N, Mikolasevic I, Krznaric Z. Prevalence, predictors and age-related sexual and erectile dysfunction in patients with inflammatory bowel disease: A tertiary centre experience. Int J Clin Pract. 2021;75:e14486. https://doi.org/10.1111/ijcp.14486 .
doi: 10.1111/ijcp.14486 pubmed: 34107145
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. Inflamm Bowel Dis. 2018;24:742–751. https://doi.org/10.1093/ibd/izx100 .
doi: 10.1093/ibd/izx100 pubmed: 29562277
Newman KL, Chedid VG, Boden EK. A Systematic Review of Inflammatory Bowel Disease Epidemiology and Health Outcomes in Sexual and Gender Minority Individuals. Gastroenterology. 2023;164:866–871. https://doi.org/10.1053/j.gastro.2022.11.048 .
doi: 10.1053/j.gastro.2022.11.048 pubmed: 37087155
Vélez C, Casimiro I, Pitts R, Streed C, Paul S. Digestive Health in Sexual and Gender Minority Populations. Am J Gastroenterol. 2022;117:865–875. https://doi.org/10.14309/ajg.0000000000001804 .
doi: 10.14309/ajg.0000000000001804 pubmed: 35537864
Drescher J. Out of DSM: Depathologizing Homosexuality. Behav Sci Basel Switz. 2015;5:565–575. https://doi.org/10.3390/bs5040565 .
doi: 10.3390/bs5040565
Obedin-Maliver J, Goldsmith ES, Stewart L et al. Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education. JAMA. 2011;306:971–977. https://doi.org/10.1001/jama.2011.1255 .
doi: 10.1001/jama.2011.1255 pubmed: 21900137
CDC. STI Treatment Guidelines. Centers for Disease Control and Prevention. Published June 13, 2023. Accessed September 27, 2023. https://www.cdc.gov/std/treatment-guidelines/default.htm
Coleman E, Radix AE, Bouman WP et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgender Health. 2022;23:S1–S259. https://doi.org/10.1080/26895269.2022.2100644 .
doi: 10.1080/26895269.2022.2100644
Martin T, Smukalla SM, Kane S, Hudesman DP, Greene R, Malter LB. Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease: A Clinical Review. Inflamm Bowel Dis. 2017;23:1285–1292. https://doi.org/10.1097/MIB.0000000000001186 .
doi: 10.1097/MIB.0000000000001186 pubmed: 28708804
Wadström H, Frisell T, Sparén P, Askling J. ARTIS study group: Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden. Ann Rheum Dis. 2016;75:1272–1278. https://doi.org/10.1136/annrheumdis-2015-208263 .
doi: 10.1136/annrheumdis-2015-208263 pubmed: 26755797
Kreijne JE, Goetgebuer RL, Erler NS et al. Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease. Aliment Pharmacol Ther. 2023;58:207–217. https://doi.org/10.1111/apt.17555 .
doi: 10.1111/apt.17555 pubmed: 37221820
Rabinowitz LG, Rabinowitz DG, Silver EM, Oxentenko AS, Williams KE, Silver JK. Disparities Persist in Inclusion of Female, Pregnant, Lactating, and Older Individuals in Inflammatory Bowel Disease Clinical Trials. Gastroenterology. 2022;163:8–13. https://doi.org/10.1053/j.gastro.2022.03.016 .
doi: 10.1053/j.gastro.2022.03.016 pubmed: 35288114
Frolkis AD, Dykeman J, Negrón ME et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145:996–1006. https://doi.org/10.1053/j.gastro.2013.07.041 .
doi: 10.1053/j.gastro.2013.07.041 pubmed: 23896172
Dames NB, Squire SE, Devlin AB et al. “Let’s talk about sex”: a patient-led survey on sexual function after colorectal and pelvic floor surgery. Colorectal Dis Off J Assoc Coloproctology G B Irel. 2021;23:1524–1551. https://doi.org/10.1111/codi.15598 .
doi: 10.1111/codi.15598
Dibley L, Norton C, Schaub J, Bassett P. Experiences of gay and lesbian patients with inflammatory bowel disease: a mixed methods study. Gastrointest Nurs. 2014;12:19–30. https://doi.org/10.12968/gasn.2014.12.6.19 .
doi: 10.12968/gasn.2014.12.6.19
Castillo G, Beaty W, Miller J et al. S911 Sexual Dysfunction Improves With Biologic Therapy in Men and Women With IBD. Off J Am Coll Gastroenterol ACG. 2021;116:S430. https://doi.org/10.14309/01.ajg.0000777176.28012.0a .
doi: 10.14309/01.ajg.0000777176.28012.0a
Chen B, Zhou B, Song G et al. Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysis. Transl Androl Urol. 2022;11:959–973. https://doi.org/10.21037/tau-22-190 .
doi: 10.21037/tau-22-190 pubmed: 35958893 pmcid: 9360519
Amarasekera C, Wong V, Jackson K et al. A Pilot Study Assessing Aspects of Sexual Function Predicted to Be Important After Treatment for Prostate Cancer in Gay Men: An Underserved Domain Highlighted. LGBT Health. 2020;7:271–276. https://doi.org/10.1089/lgbt.2018.0245 .
doi: 10.1089/lgbt.2018.0245 pubmed: 32584648
Jedel S, Hood MM, Keshavarzian A. Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:923–938. https://doi.org/10.1097/MIB.0000000000000257 .
doi: 10.1097/MIB.0000000000000257 pubmed: 25789923
Marín L, Mañosa M, Garcia-Planella E et al. Sexual function and patients’ perceptions in inflammatory bowel disease: a case-control survey. J Gastroenterol. 2013;48:713–720. https://doi.org/10.1007/s00535-012-0700-2 .
doi: 10.1007/s00535-012-0700-2 pubmed: 23124604
Fourie S, Norton C, Jackson D, Czuber-Dochan W. “These Discussions Aren’t Happening”: Experiences of People Living with Inflammatory Bowel Disease and Talking About Sexual Well-being with Health Care Professionals. J Crohns Colitis. 2021;15:1641–1648. https://doi.org/10.1093/ecco-jcc/jjab043 .
doi: 10.1093/ecco-jcc/jjab043 pubmed: 33687428 pmcid: 8495486
Christensen B, Prentice RE, Al-Ani AH, Zhang E, Bedell A, Rubin DT. Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement. Inflamm Bowel Dis. 2022;28:1465–1468. https://doi.org/10.1093/ibd/izac025 .
doi: 10.1093/ibd/izac025 pubmed: 35286382

Auteurs

Andrew Eidelberg (A)

Department of Medicine and Division of Gastroenterology, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rabb 4, Boston, MA, 02215, USA. aeidelbe@bidmc.harvard.edu.

Jordan Axelrad (J)

New York University Langone Health, New York, NY, USA.

Victor Chedid (V)

Mayo Clinic, Rochester, MN, USA.

Sarah Ballou (S)

Department of Medicine and Division of Gastroenterology, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rabb 4, Boston, MA, 02215, USA.

Adam Cheifetz (A)

Department of Medicine and Division of Gastroenterology, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rabb 4, Boston, MA, 02215, USA.

Loren G Rabinowitz (LG)

Department of Medicine and Division of Gastroenterology, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Rabb 4, Boston, MA, 02215, USA.

Classifications MeSH